Crossmark

BDNF/TrkB Signaling as a Potential Novel Target in Pediatric Brain Tumors: Anticancer Activity of Selective TrkB Inhibition in Medulloblastoma Cells

Crossref DOI link: https://doi.org/10.1007/s12031-015-0689-0

Published Online: 2015-11-27

Published Print: 2016-07

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Thomaz, Amanda

Jaeger, Mariane

Buendia, Marienela

Bambini-Junior, Victorio

Gregianin, Lauro José

Brunetto, Algemir Lunardi

Brunetto, André T.

de Farias, Caroline Brunetto

Roesler, Rafael
Funding

Funding for this research was provided by:

National Council for Scientific and Technological Development (CNPq) (484185/2012-8)

National Council for Scientific and Technological Development (CNPq) (303276/2013-4)

PRONON/Ministry of Health, Brazil (25000.162.034/2014-21)

Rafael Koff Acordi Research Fund, Children's Cancer Institute (ICI)
License Information

Text and Data Mining valid from 2015-11-27